Login / Signup

Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity.

Ilham Naeem Abd Ali Al-FatlawiVahid PouresmaeilFatemeh Davoodi-DehaghaniAida PouresmaeilAli AkhtariMasoud Homayouni Tabrizi
Published in: BMC biotechnology (2024)
Therefore, our findings suggest that the MuSCF-NPs are suitable candidates, especially for breast cancer preclinical studies.
Keyphrases
  • drug delivery
  • case control
  • fatty acid
  • wound healing
  • oxide nanoparticles
  • mesenchymal stem cells